Objectives
Define and apply statistical terms to clinical trials data.
Describe the three phases of drug development and their design methods.
Apply interim statistical analysis to your trial.
References
ClinicalTrials.gov
International Committee of Medical Journal Editors (ICMJE)
Global Pharmaceutical Industry; Statista
National Institutes of Health
MedPace
Peter Peduzzi, PhD
Ji & Wang, JCO 2013
Speaker(s): Jun Ying, PhD
Speaker(s) Bio
Dr. Jun Ying is a Professor of the Department of Biostatistics at the University of Arkansas for Medical Sciences. Dr. Ying received his Bachelors and Masters in World Economy from Fudan University, and later received a Masters in both economics and statistics from the University of Connecticut, while also completing a PhD in statistics. Some of his research interests includes predictive modeling using regression, classification, classification and regress tree, and linear discriminant analysis methods, as well as reliability and accuracy of diagnostic testing and Hierarchical Bayesian models and computation. Dr. Ying currently works on the following research projects: Biostatistics Core, UAMS Winthrop P. Rockefeller Cancer Institute; Arkansas Center for Birth Defects Research and Prevention; and VA Burn Pit Study Group.
